Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

The Greeley Company Names Greg Kopulos as President

Greeley

The Greeley Company (Greeley), a division of The Chartis Group (Chartis) and a leader in clinical quality and patient safety services and solutions, is pleased to announce that Greg Kopulos has joined the firm as its new President. Kopulos will serve as a member of both Chartis’ and Greeley’s executive leadership teams. As President, Kopulos will be responsible for all of Greeley’s financial, operational and service areas including Patient Safety and Clinical Compliance, Medical Staff Services Optimization, Physician Education and Interim Staffing Solutions. He will also lead the company’s growth strategies and drive Greeley’s commitment to materially improve patient safety, quality and outcomes. “We are delighted to welcome Greg as Greeley’s new President,” said Ken Graboys, CEO of The Chartis Group. “Greeley has long been an essential resource for leading healthcare organizations who rely on the company’s expertise to meet their clinical quality and patient safety objectives. Greg’s proven leadership comes at an exciting time as Greeley continues to grow and serve US providers in their most mission-critical areas.” Kopulos joins Greeley from GE Healthcare (GEHC) where he most recently served as Senior Vice President of Strategy focused on leading GEHC’s global go-to-market transformation. He held multiple senior leadership roles within GEHC during his 19-year tenure, including Senior Vice President and COO – Global Services, and Chief Operating Officer – US & Canada Region. “I’m humbled and energized to join a company guided by its mission to serve” said Kopulos. “With the deep expertise of our practice leaders and a proven reputation in the market, Greeley is committed to the advancement of clinical quality and patient safety and will continue to make a material impact for the clients we serve.” Kopulos assumes the role as part of Greeley’s and Chartis’ growing investment in their Clinical Quality and Patient Safety offerings and capabilities. Andrew Resnick, MD, a nationally recognized leader in clinical quality and safety, recently joined Chartis as Chief Medical and Quality Officer. Dr. Resnick comes from Mass General Brigham where he served as Senior Vice President and Chief Quality and Safety Officer at Brigham Health. Christian Dankers, MD, recently joined Chartis as Associate Chief Medical and Quality Officer, following his role as an Associate Chief Quality Officer at Mass General Brigham. Sheri Winsper, RN, MSN, MHA recently joined Greeley as Vice President of External Peer Review/Clinical Quality & High Reliability, following her role as Senior Vice President, Quality Measurement at the National Quality Forum (NQF). Prior to his time at GEHC, Kopulos served as Vice President, Business Development for an equipment maintenance insurance firm and Vice President of Finance at a long-term care company. Greg obtained his CPA and started his career with Arthur Andersen providing consulting services to middle market clients. Kopulos earned a Bachelor of Arts in Accounting from University of Wisconsin-Whitewater. He earned a Master’s in Business Administration with International Focus from Marquette University. About The Greeley Company The Greeley Company (Greeley), a division of The Chartis Group®, is a leader in patient safety and clinical quality consulting. Greeley has utilized its proven methodology to help organizations improve efficiency, comply with regulations and standards, achieve practitioner engagement and alignment, and excel in delivering high-quality, cost-effective patient care for more than 30 years. For more information, visit greeley.com. About The Chartis Group® The Chartis Group (Chartis) provides comprehensive advisory services and analytics to the healthcare industry. With an unparalleled depth of expertise in strategic planning, performance excellence, informatics and technology, digital and emerging technologies, and health analytics, Chartis helps leading academic medical centers, integrated delivery networks, children's hospitals and healthcare service organizations achieve transformative results. Chartis has offices in Atlanta, Boston, Chicago, New York, Minneapolis and San Francisco. For more information, visit chartis.com. Contact Details Hot Paper Lantern Brooke Ferreri +1 212-931-6182 bferreri@hotpaperlantern.com Company Website https://greeley.com/

February 10, 2022 09:00 AM Eastern Standard Time

FreshEdge Launches New Website

FreshEdge

FreshEdge, a family of produce and specialty food companies, has launched a refreshed and expanded www.freshedgefoods.com. FreshEdge partnered with DMA Solutions (Dallas, Texas), a marketing agency dedicated to exclusively serving the fresh produce industry. The website creates opportunities for connecting with FreshEdge’s operating companies and engaging in what makes their family unique. FreshEdge now operates with 1,640 employees, approximately 700,250 square feet of warehouse space, with a fleet of more than 650 trucks, delivering fresh food to customers in 22 states. Through rapid growth and consistent execution, FreshEdge has quickly amassed a reputation for adding value throughout the fresh foods industry. “FreshEdge’s new website is a splash of freshness,” said Steve Grinstead, CEO of FreshEdge. “It also symbolizes who we are – a growing family of customer-obsessed fresh food companies who care.” Greg Corsaro, President and COO of FreshEdge, added, “The revamped website reflects FreshEdge’s value proposition of providing dependable, customized solutions with cutting-edge technology for consistent, reliable delivery of fresh food with a sense of family and trust.” “We’re excited about the unique space this new website delivers for connecting FreshEdge, its family, and our industry partners,” said Daniel Corsaro, President of Indianapolis Fruit (FreshEdge retail operating company) and participant in the development of the new site. About FreshEdge FreshEdge was formed in 2019 through the combination of Get Fresh Produce (Bartlett, IL, founded in 1982) and the IF&P Foods family of companies, primarily composed of Indianapolis Fruit (founded 1947) and Piazza Produce (founded 1970). McCartney Produce (Paris, TN) joined the FreshEdge family in November 2020 followed by Valley Produce (Knoxville, TN) in June 2021, Vine Line (Grand Rapids, MI) in October 2021, and Monteverde’s (Pittsburgh, PA) in November 2021. Collectively, these leading fresh food distribution companies have several hundred years’ combined experience serving the grocery and food service industries. In addition, FreshEdge includes two Garden Cut branded fresh-cut processing facilities, a tomato re-packer, a USDA fresh kitchen (CIBUS Fresh), and two transportation companies. Today, FreshEdge is a category leader in providing both the foodservice and retail industries with fruit, vegetables, fresh grab-n-go offerings, dairy, floral and specialty products. For more, visit www.freshedgefoods.com. Contact Details FreshEdge Greg Corsaro +1 317-981-3440 gcorsaro@freshedgefoods.com Company Website https://www.freshedgefoods.com/

February 10, 2022 07:43 AM Eastern Standard Time

Image

Regenerative Medicine Company Vascudyne Relocates to High Capacity GMP Manufacturing Facility

Vascudyne, Inc.

Vascudyne, Inc., a biotechnology trailblazer in regenerative medicine, announced today that it has relocated to 15,000 sq. ft. of recently remodeled manufacturing, warehouse, laboratory, and office space. This new facility is needed to meet increased demand for research and development and manufacturing of Vascudyne’s TRUE™ Tissue technology that is unique and 100% natural. Nothing synthetic or artificial is ever used in the manufacturing process, in contrast to other regenerative medicine cardiovascular devices with synthetic polymer-based scaffolds that slowly degrade in the body and may lead to adverse immune response. Vascudyne announced in July the successful first human use of its TRUE™ Graft for hemodialysis access in end-stage renal disease patients. “The addition of a dedicated 5,000 sq. ft. ISO 7 Cleanroom manufacturing facility is paramount for the successful continuation of our TRUE Graft clinical studies,” said Cory Pries, Director of Quality at Vascudyne. “The expandable manufacturing capacity we have added is designed to support our current pilot clinical studies all the way to initial commercialization.” "We are dedicating 2,500 sq. ft. of the ISO 7 Cleanroom space to our new product development pipeline for coronary artery bypass graft, heart valves, and surgical patches," added Dr. Zeeshan Syedain, Vascudyne’s Chief Scientific Officer. “While we are initially focusing on cardiovascular applications for our TRUE Tissue technology, we can readily manufacture products and delivery systems for a range of medical devices, implantation sites, and geometries. We are excited to develop implantable biomaterials that are ready to use, off-the-shelf, and regenerative.” Vascudyne announced in December the closing of its Series A financing round for $10M that has fueled its growth and enabled the company’s relocation to the new facility. “Our investors’ continued support and promising early results from TRUE Graft’s first in man pilot study have propelled our growth,” said Rick Murphy, Vascudyne’s Chief Operating Officer. “We are establishing a strong presence in the epicenter of the Medical Alley, the Silicon Valley of Healthcare, and are creating excellent employment opportunities for talented people in the area. The move to this new facility positions us well to meet growing global demand for our products.” Vascudyne licensed its proprietary TRUE Tissue technology developed by world renowned tissue engineering leader Robert Tranquillo, PhD, Distinguished McKnight University Professor, and his colleagues from the University of Minnesota in 2017. TRUE Graft is not available for commercial sale. About Vascudyne Headquartered in the heart of Medical Alley in Minnesota, Vascudyne is on a mission to improve patient care with regenerative biomaterials that are inspired by nature. Vascudyne, a privately held company founded in 2014, uses the TRUE™ Tissue technology to develop TRUE to Nature™ biomaterials for soft tissue repair and replacement. For more information, please visit https://www.vascudyne.com/. About TRUE Tissue Technology TRUE™ Tissue is developed from cells isolated from donor tissue and is 100% biological. There are no synthetic materials or chemical fixation used, and implanted tissues are completely cell-derived and acellular. The TRUE Tissue technology can be readily shaped into tubes, sheets, and other geometries making it suitable for many soft tissue applications, is mechanically comparable to native tissues, and is a ready to use, off-the-shelf allograft. Forward Looking Statements This announcement contains forward-looking statements. Such statements may include, without limitation, statements identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "potential" or similar expressions. These statements relate to future events or Vascudyne’s clinical development programs, reflect management’s current beliefs and expectations and involve known and unknown risks, uncertainties and other factors that may cause Vascudyne’s actual results, performance or achievements to be materially different. Vascudyne undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future presentations or otherwise, except as required by applicable law. Contact Details Sandy Williams, Marketing Director swilliams@vascudyne.com Company Website https://vascudyne.com/

February 09, 2022 09:23 AM Eastern Standard Time

Image

Shatterproof Receives $5 Million Gift from MacKenzie Scott

Shatterproof

Shatterproof, a national nonprofit organization dedicated to reversing the addiction crisis in the United States, today announced that it is a recipient of a $5 million grant from MacKenzie Scott, American philanthropist, to expand its work on addressing substance use disorder. The gift will be used to scale Shatterproof’s work using science-based solutions to make change by revolutionizing the addiction treatment system, breaking down addiction-related stigmas, educating and empowering our communities and addressing policy change at the federal and state level. Between April 2020 and May 2021, the CDC reported that United States experienced more than 100,000 overdose deaths which is a 30 percent increase from previous years. According to a study by SAMSHA on substance use and health, the COVID-19 pandemic has had a negative impact on the nation’s well-being and alcohol and drug use is impacting nearly 40 million Americans. “Our country is suffering, and it is critical that Shatterproof scale the implementation of its science-based strategies and get our tools and resources into the hands of as many of our loved-ones in need as possible,” shared Gary Mendell, Shatterproof Founder & CEO. “Thanks to the generosity of MacKenzie Scott, we will be able to continue to further grow our life-saving work. While we are proud of our results to date, there is so much more work to do to meet the needs of the millions of families impacted by this disease.” We are so grateful that she has recognized the importance of addressing this urgent need in our country and investing in Shatterproof.” In 2020, Shatterproof launched www.TreatmentATLAS.org, an Addiction Treatment Locator, Assessment and Standards (ATLAS®) platform, which aims to empower the public to find high-quality treatment services and ultimately drive the delivery of quality addiction treatment nationally. ATLAS is currently available in six states (DE, LA, MA, NY, NC, WV) and will expand to five more states this year (CA, FL, OK, NJ, PA). Shatterproof also launched the Movement to End Addiction Stigma, an evidence-based national strategy to address widespread stigma toward those with substance use disorder. Additionally, Shatterproof, in collaboration with The Hartford, released the Shatterproof Addiction Stigma Index a first-of-its-kind measurement tool, was designed to assess attitudes about substance use and people who use substances. Educational materials and helpful assessments and resources are available at www.Shatterprooff.org for individuals and families in need of help and support. About Shatterproof: Shatterproof is a national nonprofit organization dedicated to reversing the addiction crisis in the United States. Shatterproof harnesses the models of business, the rigor of science and the power of a national movement to create change and save lives through three pillars of work: revolutionizing the addiction treatment system, breaking down addiction-related stigmas and supporting and empowering our communities. To learn more visit www.Shatterproof.org. Contact Details Shatterproof Vanessa Shimer +1 203-954-8053 vshimer@shatterproof.org Company Website https://www.shatterproof.org/

February 08, 2022 03:02 PM Eastern Standard Time

GROUNDWORK BIOAG AND NOVATERO EXPAND MYCORRHIZAL BIO-PLATFORM FOR BRAZIL

Groundwork BioAg

Groundwork BioAg and its exclusive Brazilian distribution partner, NovaTero BioAg, announced a new product offering for Brazilian farmers this growing season – Rootella® BR ULTRA – which expands the reach to in-furrow and seed treatment application methods in soybean, corn and other cereals. Rootella BR ULTRA is the highest concentrated mycorrhizal inoculant in the market, containing 167,000 viable propagules per gram of Rhizophagus intraradices, with an application rate of as low as 15 grams per hectare. “As farmers manage the unseasonably dry weather, our expanded product portfolio offers additional choices for farmers in Brazil, especially as many switch to Safrinha,” said Bernardo Arnaud, NovaTero Chairman. “Farmers across Brazil continue to benefit from adding Rootella to their farm management practices to protect soil and plant health while extending above and below ground insurance against environmental stresses.” For the past three years, NovaTero has helped Brazilian farmers to naturally increase yield, reduce dependency on phosphorus and improve carbon sequestration in soil by applying the proven Rootella BR mycorrhizae inoculants. “As part of our strategy to expand our mycorrhizal bio-platform, we continue to set the standard for concentration of cost-effective, commercial scale mycorrhizae,” said Dr. Yossi Kofman, Co-Founder and CEO of Groundwork BioAg. “As the impact of climate change continues around the world, we are committed to help increase the productivity of major crops – like those in key breadbaskets such as Brazil. As the ‘queen of biologicals,’ mycorrhiza offers the strongest natural defense against chronic drought while reducing the need for synthetic fertilizers.” After being granted the only definitive commercial registration in Brazil, the companies’ exclusive partnership has accelerated innovation to meet demand of the rapidly growing Brazilian market, where the biologicals market is projected to show a double digit CAGR in the coming years. The Rootella BR portfolio includes two of the most concentrated formulations of mycorrhizae on the market today. About Groundwork BioAg Groundwork BioAg, a global bioagriculture company, leverages the natural power of mycorrhizal fungi to improve the productivity, sustainability and profitability of commercial agriculture and expand regenerative agriculture practices. Groundwork BioAg is the first to use innovative techniques to solve challenges inherent in high-volume mycorrhizal inoculant production. We will not rest until every hectare of arable land is protected by mycorrhizae and every farmer benefits from higher crop yields while preserving our soils. For more information, visit www.groundworkbioag.com. Contact Details AgTech PR for Groundwork BioAg Jennifer Goldston +1 816-260-0040 jennifer@agtechpr.com Company Website https://www.groundworkbioag.com

February 08, 2022 08:30 AM Central Standard Time

Kramer enriches its end-to-end solutions for Enterprise and Education applications with the new Kramer Collaboration Devices

Kramer Electronics

Kramer Electronics Ltd. is pleased to announce the release of its new Kramer Collaboration Devices, the latest addition to its end-to-end Pro AV solutions for Enterprise and Education applications. The new product line, which includes advanced cameras, a communication bar and a speakerphone, offers outstanding AV quality, flexibility and simplicity. Kramer’s complete solutions for Enterprise meeting spaces, schools and universities meet customers’ needs for complete, integrated solutions from a single, trusted partner that provides certified solutions, market-leading warranties and end-to-end support, all under one roof. Offering simple setup and seamless use, it is agnostic to all UC applications, and supports multiple conferencing platforms. Kramer Collaboration Devices are designed for varied spaces from small huddle rooms up to large boardrooms, classrooms and auditoriums. They ensure all participants, whether in the room or connecting remotely, consistently enjoy superb interactions, with an immersive audio and video experience. With Kramer Collaboration Devices, all participants can see and be seen as well as hear and be heard clearly – enabling meaningful and effective collaboration. An integral part of Kramer end-to-end solutions for Enterprise and Education applications, Kramer Collaboration Devices are fast and simple to deploy. They can easily be combined with Kramer's in-room A/V signal management and control products for a complete collaborative, hybrid experience. “With workplace norms and needs changing across business and education markets, our end-to-end solutions are building the foundation for truly inclusive hybrid interaction spaces,” says Gilad Yron, Kramer’s CEO. “The addition of the new line of Kramer Collaboration Devices is the latest step towards this vision, helping ensure engaging experiences for all participants and successfully bridging the gap between in-person and remote interactions.” The new Kramer Collaboration Devices product line includes: K-Speak – A compact speakerphone with 360° omnidirectional audio pickup that enhances the audio experience for everyone. Perfect for any room size where additional audio coverage is needed. K-Bar –An all-in-one video and audio communication bar that allows participants to quickly start collaborating. Ideal for small to mid-sized spaces where an all-in-one device saves space and cable clutter. K-180Mini – A smart, 4K wall-mount panoramic camera with integrated microphone, that captures clear video across a full 180° field of view. Designed for small rooms and huddle rooms. K-CamHD – A professional HD PTZ camera for versatile video capture that ensures a clear view of all meeting attendees, with special attention wherever needed. Ideal for varied spaces and use cases, ranging from medium sized rooms up to board rooms, classrooms and auditoriums. K-Cam4K –An ultra-HD PTZ camera for premium-clarity video in large spaces that puts every meeting in sharp focus, with crystal-clear, ultra-high-definition video capture. Supports the most advanced and challenging setups in large meeting rooms and educational spaces. About Kramer We are dedicated to delivering better, smarter solutions that enhance physical-digital engagement and collaboration. Kramer solutions are based on our cutting-edge products and technologies for traditional AV, AV over IP, unified communication and collaboration (UCC) and wireless collaboration, and advanced management and control. www.kramerav.com Contact Details Ornit Sade Benkin +972 52-332-7700 osade@kramerav.com Company Website https://www.kramerav.com/

February 08, 2022 08:00 AM Eastern Standard Time

AIHM Integrative Health & Medicine Fellowship Application Now Open

Academy of Integrative Health and Medicine

The Academy of Integrative Health and Medicine (AIHM) is now accepting applications for its Spring 2022 Fellowship cohort. Applications are available at https://aihm.org/fellowship/. AIHM’s Integrative Health and Medicine Fellowship is a hybrid program designed for busy health professionals who have completed postgraduate education and hold an active license in a healthcare profession. The 1,000-hour program, which blends online learning with a clinical immersion experience, provides clinicians the opportunity to explore the diverse applications of integrative medicine and learn effective, interprofessional tools that can immediately be incorporated into their practice and patient care model. “With patient interest in integrative therapies on the rise, and more clinicians embracing such practices, we expect more providers than ever to apply to our fellowship program this year,” said Dr. Erika Cappelluti, AIHM fellowship director. In addition to evidence-based online learning modules and a clinical immersion, clinicians attend three retreats during the fellowship, which cover topics such as nutrition, botanical medicine, dietary supplements, biofield science, Chinese medicine, yoga, and meditation—all explored in a dynamic, interpersonal, group setting. The AIHM Fellowship is approved by the American Board of Integrative Medicine (ABOIM) and recognized by the Academic Consortium for Integrative Medicine & Health. Graduating Fellows who hold an MD or DO degree may be eligible to sit for the board exam and become board certified through the ABOIM. All graduates will receive a certificate of completion and can use the FAIHM designation in their credentials. For more information, practitioners are encouraged to attend the virtual informational sessions: Open House with a Fellowship Graduate on Thursday, Feb. 10, at 5 p.m. PT Open House with Fellowship Faculty on Thursday, March 10, at 5 p.m. PT For additional information about the AIHM Fellowship Program, visit https://aihm.org/fellowship/. Founded in 1978, the Academy of Integrative Health and Medicine (AIHM) is the leading interprofessional organization for traditional, complementary and integrative health practitioners worldwide. In 2001, AIHM merged with the Academic Collaborative of Integrative Health (ACIH). Together, they are working to advance integrative health on a global scale and transform health and wellness through education, leadership, collaboration, research and advocacy. For more information, visit aihm.org or follow @aihmglobal on Facebook, Instagram, and Twitter. Contact Details Carol Stevenson +1 661-713-6879 carol@growthledge.com Company Website https://aihm.org

February 07, 2022 06:10 PM Eastern Standard Time

How The US is Leading the World to End COVID

YourUpdateTV

After two years of dealing with COVID issues, everyone is sick of arguing about masks and wants the supply chain fixed, the economy to rebound and kids to stay in school. The United States has been the global leader in the fight donating more than a half a billion vaccine doses and hundreds of millions of dollars. More needs to be done, and it’s in the hands of Congress to pass an emergency plan to End COVID Now. YourUpdateTV spoke to Michelle Nunn, President & CEO of CARE USA and Dr. Angela Wakhweya, CARE USA Senior Director, Health Equity and Rights Team to discuss how the US is leading the world to end COVID. A video accompanying this announcement is available at: https://youtu.be/vbbO4zX15Qw An emergency plan being considered by Congress will put billions of dollars into vaccines that could help reduce the risk of new variants developing that could threaten the United States and finally allow us to get back to normal. END COVID NOW is up with new advertisements across the country starting today, Lead The World and Variants are running nationwide on TV and cable as well as digital and streaming platforms. The Campaign to End COVID Now says This pandemic isn’t going away. Instead, it is a chronic disaster for everyone – families, communities, the whole country. The solution is straightforward and staring us in the face – we must achieve global immunity through ensuring everyone in the world has access to vaccines as quickly as possible. If not, we will continue to see variant after variant spread through our neighborhoods, disrupting and threatening our lives and our children’s lives. To learn more, visit EndCovidNow.com About the Campaign to End Covid: The End Covid Now campaign was formed by public health experts, scientists, and other concerned Americans to pressure our nation’s leaders and pharmaceutical companies to ensure future variants don’t shut down America. The plan to end COVID-19 consists of investing more money in vaccine manufacturing, sharing the vaccine formula so other countries can manufacture and distribute them, and working with allied countries to get more people vaccinated so Americans are safe from future variants. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

February 07, 2022 12:03 PM Eastern Standard Time

Video

The Greeley Company Names Sheri Winsper as VP of External Peer Review/Clinical Quality & High Reliability

Greeley

The Greeley Company (Greeley), a leader in clinical quality and patient safety, is pleased to announce that Sheri Winsper has joined the firm as Vice President of External Peer Review (EPR) and Clinical Quality & High Reliability (CQHR). Winsper brings deep expertise providing practical and sustainable solutions to enable organizations and the patients they serve to achieve high quality, safe, and efficient care. Through her EPR leadership, Winsper will collaborate with clients to provide practical, timely, and reliable performance measurement systems. Additionally, she will further advance Greeley’s CQHR consulting services through operational oversight, strategy development, and consultation. Winsper’s extensive healthcare experience includes a decade of acute care nursing and an additional 13 years of leadership in Clinical Quality & Patient Safety. She joins Greeley from National Quality Forum (NQF) where she served as Senior Vice President, Quality Measurement. In this role she worked strategically with NCQA, AHA, large health systems, CMS, AHRQ, the Veteran’s Administration, and America’s Health Insurance Plans (AHIP) to move quality measurement and improvement efforts toward making care high value for all. “My passion for data-driven, evidence-based programs that utilize nationally endorsed measures of risk reduction and high reliability outcomes closely aligns with Greeley’s commitment to helping organizations transform clinical practices,” Winsper said. “I’m thrilled to join a leading firm that provides best in class services, and I look forward to utilizing my EPR and CQHR experience to achieve the quality and highly reliable results organizations seek, and patients deserve.” Prior to her tenure at NQF, Winsper served as Vice President, Clinical Quality & Patient Safety/Chief Quality Officer at Texas Health Resources (THR). In this leadership capacity she provided system-wide leadership and risk management of clinical quality improvement, accreditation and regulatory operations, infection prevention, high reliability organization and culture of safety, and oversaw clinical risk management teams across multiple hospitals and physician clinics. Winsper served as Executive Director, Quality & Patient Safety, Center for Clinical Excellence (CCE) at Loyola University Health System prior to her position at THR. She also held several leadership positions at Baylor Scott & White Health (BSWH) including Vice President, COO/CQO of the STEEEP® Global Institute (SGI) and Vice President of Performance Measurement & Reporting at BSWH’s Institute for Health Care Research & Improvement. Winsper also previously served as Vice President, Clinical Quality, Health Research & Educational Trust (HRET) for American Hospital Association. Winsper received a Master of Science in Nursing Administration and a Master of Science in Health Care Administration from University of Texas at Arlington, TX. She received a Bachelor of Science in Nursing at Oklahoma Baptist University, Shawnee, OK. About The Greeley Company The Greeley Company (Greeley), a division of The Chartis Group®, is a leader in patient safety and clinical quality. Greeley has utilized its proven methodology to help organizations improve efficiency, comply with regulations and standards, achieve practitioner engagement and alignment, and excel in delivering high-quality, cost-effective patient care for more than 30 years. For more information, visit greeley.com. About The Chartis Group® The Chartis Group (Chartis) provides comprehensive advisory services and analytics to the healthcare industry. With an unparalleled depth of expertise in strategic planning, performance excellence, informatics and technology, digital and emerging technologies, and health analytics, Chartis helps leading academic medical centers, integrated delivery networks, children's hospitals and healthcare service organizations achieve transformative results. Chartis has offices in Atlanta, Boston, Chicago, New York, Minneapolis and San Francisco. For more information, visit chartis.com. Contact Details Hot Paper Lantern Brooke Ferreri +1 212-931-6182 bferreri@hotpaperlantern.com Company Website https://greeley.com/

February 07, 2022 09:00 AM Eastern Standard Time

1 ... 232 233 234 235 236 ... 301